Literature DB >> 5121698

Summary of papers delivered at the Conference on Staging in Hodgkin's Disease (Ann Arbor).

D W Smithers.   

Abstract

Entities:  

Mesh：

Year:  1971        PMID： 5121698

Source DB:  PubMed          Journal:  Cancer Res        ISSN： 0008-5472            Impact factor:   12.701


× No keyword cloud information.
  4 in total

1.  Long term outcome of ocular adnexal lymphoma subtyped according to the REAL classification. Revised European and American Lymphoma.

Authors:  C Auw-Haedrich; S E Coupland; A Kapp; A Schmitt-Gräff; R Buchen; H Witschel
Journal:  Br J Ophthalmol       Date:  2001-01       Impact factor: 4.638

2.  Addition of rituximab is not associated with survival benefit compared with CHOP alone for patients with stage I diffuse large B-cell lymphoma.

Authors:  Bo Jia; Yuankai Shi; Suyi Kang; Sheng Yang; Shaoxuan Hu; Yexiong Li; Mei Dong; Weihu Wang; Jianliang Yang; Liqiang Zhou; Peng Liu; Shengyu Zhou; Yan Qin; Lin Gui; Changgong Zhang; Hua Lin; Shanshan Chen; Lin Wang; Xiaohui He
Journal:  Chin J Cancer Res       Date:  2015-10       Impact factor: 5.087

3.  Simultaneous occurrence of Hodgkin's lymphoma and multiple myeloma: A case report and review of the literature.

Authors:  Chen Huang; Guimin Zhao; Lianjing Wang; Huichao Zhang; Xiaolin Wu; Mingzeng Zhang; Ruijuan Ma; Ling Wang; Yueping Liu; Lihong Liu
Journal:  Oncol Lett       Date:  2016-04-27       Impact factor: 2.967

4.  The usefulness of (18)F-FDG PET/CT for assessing methotrexate-associated lymphoproliferative disorder (MTX-LPD).

Authors:  Shiro Watanabe; Osamu Manabe; Kenji Hirata; Noriko Oyama-Manabe; Naoya Hattori; Yasuka Kikuchi; Kentaro Kobayashi; Takuya Toyonaga; Nagara Tamaki
Journal:  BMC Cancer       Date:  2016-08-15       Impact factor: 4.430
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.